Ritholtz Wealth Management Amneal Pharmaceuticals, Inc. Transaction History
Ritholtz Wealth Management
- $5.23 Billion
- Q4 2025
A detailed history of Ritholtz Wealth Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 102,722 shares of AMRX stock, worth $1.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
102,722
Previous 103,421
0.68%
Holding current value
$1.2 Million
Previous $1.04 Million
15.46%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding AMRX
# of Institutions
264Shares Held
152MCall Options Held
357KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA17.9MShares$208 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY12.3MShares$144 Million2.03% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$144 Million7.99% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$131 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.73MShares$66.7 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.76B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...